Developer docs
API playgroundTry for free, no card

Search company profiles

Centre for Brain Research (CBR) IISc

Full company profile

uuid0043m3r

Namestring
Centre for Brain Research (CBR) IISc
Legal namestring
Centre for Brain Research
Websiteurl
cbr-iisc.ac.in
Company typeenum
Private
Founded yearint
2022
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersBangalore, India
HQ citystring
Bangalore
HQ countrystring
India
HQ regionstring
Asia
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
neuroscience research, brain aging studies, longitudinal cohort studies, neurodegenerative disease research, biomarker discovery
Industry1 code
1Cognitive & Behavioral Neurology (Dementia/Memory Disorders)
CodeHLAKAIAHPrimaryYes
NAICS code1 code
  • Services for the Elderly and Persons with Disabilities624120
SIC code1 code
  • In Vitro & In Vivo Diagnostic Substances2835
Product category
Neuroscience Research
Social media profiles3 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Philanthropic Funding
TypeLicensing Royalties
Description

CBR was established with a generous gift from Dr. Kris Gopalakrishnan (co-founder of Infosys) and Mrs. Sudha Gopalakrishnan. Principally funded by Pratiksha Trust with Rs 450 crore commitment for aging brain research. Additional donors include Late Ms Sharwaree Gokhale, Software AG India, Ms Nirmala Govindan Pullur, and Late Ms Amba Subba Rao.

cbr-iisc.ac.in:443
2Research Grants
TypeManaged Services
Description

CBR receives research grants for specific projects from several granting agencies including DBT-India, ICMR-India, SERB-India, Alzheimer's Association-USA, and others.

cbr-iisc.ac.in:443
3Donations
TypeAffiliate Referral
Description

CBR accepts one-time donations, recurring donations, legacy giving, and corporate sponsorships. US donors can donate through Charities Aid Foundation (CAF) America.

cbr-iisc.ac.in
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Infrastructure, Operations, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

The Centre for Brain Research conducts longitudinal aging cohort studies to understand normal and pathological brain aging, identify risk factors for dementia, and develop early detection biomarkers for Alzheimer's and related neurodegenerative disorders. Its core programs include the rural SANSCOG cohort, urban TLSA cohort, YLOPD Parkinson's study, and GenomeIndia genomics initiative, alongside a Biomarker Centre of Excellence focused on scalable blood-based diagnostic methods.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Sequenced 10000 genomes milestone achieved
+2 more records
Product and service5 records
1CBR-SANSCOG Study
CategoryLongitudinal Aging Cohort Study
Description

A first-of-its-kind longitudinal aging cohort study in India focusing on the rural aging population in Srinivaspura, designed to identify risk and protective factors for dementia and cognitive decline through multi-year clinical, cognitive, biochemical, and neuroimaging assessments.

2CBR-TLSA Study (Tata Longitudinal Study on Aging)
CategoryLongitudinal Aging Cohort Study
Description

A longitudinal aging cohort study on urban residents of Bangalore, India, funded by Tata Trusts, investigating cognitive trajectories, biomarkers, and risk factors for dementia in an urban Indian population.

3YLOPD Study
CategoryNeurodegenerative Disease Cohort Study
Description

A longitudinal study on Young and Late-onset Parkinson's Disease investigating clinical, genetic, and biochemical characteristics of Parkinson's disease in the Indian population.

4GenomeIndia Initiative
CategoryGenomics Research Initiative
Description

A comprehensive catalog of genetic variations for India's population designed to capture the unique genetic diversity across the country, including a milestone of sequencing 10,000+ genomes.

5Biomarker Centre of Excellence
CategoryBiomarker Discovery and Diagnostics
Description

A dedicated center for systematic evaluation of blood biomarkers and discovery of new biomarkers relevant to the Indian population, including development of scalable finger-prick testing methods for early detection of dementia and neurodegenerative diseases.

Scale indicator8 records

Each record includes

Type, Value, Description, Source

Partnership4 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-04-09
Description

MoU signed April 2025 to establish long-term association on scientific research and capacity-building in healthy brain aging. Combines CBR's clinical and scientific expertise with Gates Ventures' commitment to overcoming R&D challenges in Alzheimer's and related dementias. Leverages fluid biomarkers to predict onset and monitor progression of dementia. Establishes Biomarker Centre of Excellence at CBR for evaluating blood biomarkers and developing scalable finger-prick testing methods. Cooperation enabled via Alzheimer's Disease Data Initiative (ADDI) and Global Research and Imaging Platform (GRIP).

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-03-14
Description

Landmark international partnership launched March 2025 to create a dynamic research ecosystem for brain health. Combines expertise in blood-based biomarkers, AI-driven data analysis, and digital cognitive monitoring tools. Leverages diverse population studies across India and UK, working with Health Data Research UK. Establishes cross-institutional collaboration mechanisms including research internships, joint educational initiatives, and resource sharing. Focus on fluid biomarkers characterization and AI-powered data infrastructure development.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2025-03-14
Description

Partnership leveraging data and extensive epidemiological datasets to maximize research impact in brain aging research, working alongside UK DRI.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2024-05-28
Description

AI-driven health behaviour innovations collaboration. Wipro teams up with CBR for AI-driven health behaviour innovations.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Non-profit neuroscience research organization generating large-scale open datasets, atlases, and tools. Comparable to CBR in combining large-scale data generation (CBR's 10,000+ genomes and cohorts) with a translational neuroscience mission.

TypeDirect peer
Description

UK's national dementia research institute, directly comparable as a brain-aging and neurodegeneration research organization. CBR and UK DRI signed an MoU in March 2025, integrating biomarker, AI, and digital cognitive monitoring programs across India and UK cohorts.

TypeBroad incumbent
Description

U.S. federal agency that funds and conducts Alzheimer's and related dementias research at scale, including the Alzheimer's Disease Research Center network. Comparable as the dominant funder/coordinator of dementia cohort and biomarker research in the U.S.

TypeRegional player
Description

Sweden-based academic research center studying aging, dementia, and cognitive decline through longitudinal cohorts (e.g., SNAC-K). Comparable scientific agenda to CBR but based in Europe, with similar population-cohort methodology.

TypeDirect peer
Description

Non-profit research organization focused on Alzheimer's disease prevention, early detection, and biomarker research. Comparable to CBR in dementia-specific translational research mission and population-based study orientation.

TypeDirect peer
Description

Independent non-profit biological research institute with strengths in neuroscience and age-related neurodegeneration. Comparable to CBR in non-profit research mission and bench-to-translational pipeline structure.

TypeDirect peer
Description

Independent non-profit research institute focused on aging and age-related disease, including neurodegeneration. Comparable to CBR's research-only structure, disease-mechanism focus, and translational aging science orientation.

TypeDirect peer
Description

Germany-based non-profit research institute studying the biology of aging and age-related disease, including neurodegeneration. Comparable to CBR as a dedicated aging-and-dementia basic/translational research entity.

TypeDirect peer
Description

NIH-designated Alzheimer's Disease Research Center combining longitudinal cohorts, biomarker discovery, and clinical translation. Comparable to CBR in disease-focused, multimodal biomarker + cohort infrastructure.

TypeDirect peer
Description

Academic research center running long-running longitudinal cohort studies of aging and dementia (e.g., Religious Orders Study, Memory and Aging Project). Directly comparable to CBR-SANSCOG/TLSA in cohort-based dementia risk-factor research.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles6 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Centre for Brain Research (CBR) IISc

Neuroscience Researchcbr-iisc.ac.in

Centre for Brain Research (CBR) IISc firmographics

Firmographics
Name
Centre for Brain Research (CBR) IISc
Legal name
Centre for Brain Research
Website
https://cbr-iisc.ac.in
Company type
Private
Founded year
2022
Operating status
Operating
Headcount range
101–250 employees
Ownership category
akta.pro rank

Centre for Brain Research (CBR) IISc industry classification

Industry
Product category
Neuroscience Research
NAICS
Services for the Elderly and Persons with Disabilities (624120)
SIC
In Vitro & In Vivo Diagnostic Substances (2835)
akta.pro primary industry
Cognitive & Behavioral Neurology (Dementia/Memory Disorders) (HLAKAIAH)

Keywords

  • Neuroscience research
  • Brain aging studies
  • Longitudinal cohort studies
  • Neurodegenerative disease research
  • Biomarker discovery

Where Centre for Brain Research (CBR) IISc is headquartered

Location

Headquarters

HQ city
Bangalore
HQ country
India
HQ region
Asia

Offices2 records

Markets served

Centre for Brain Research (CBR) IISc business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Technology or R&D, Infrastructure, Operations, Marketing or Sales

Revenue model

  1. Philanthropic Funding: CBR was established with a generous gift from Dr. Kris Gopalakrishnan (co-founder of Infosys) and Mrs. Sudha Gopalakrishnan. Principally funded by Pratiksha Trust with Rs 450 crore commitment for aging brain research. Additional donors include Late Ms Sharwaree Gokhale, Software AG India, Ms Nirmala Govindan Pullur, and Late Ms Amba Subba Rao.
  2. Research Grants: CBR receives research grants for specific projects from several granting agencies including DBT-India, ICMR-India, SERB-India, Alzheimer's Association-USA, and others.
  3. Donations: CBR accepts one-time donations, recurring donations, legacy giving, and corporate sponsorships. US donors can donate through Charities Aid Foundation (CAF) America.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Centre for Brain Research (CBR) IISc product offering

Product offering

Core offering

The Centre for Brain Research conducts longitudinal aging cohort studies to understand normal and pathological brain aging, identify risk factors for dementia, and develop early detection biomarkers for Alzheimer's and related neurodegenerative disorders. Its core programs include the rural SANSCOG cohort, urban TLSA cohort, YLOPD Parkinson's study, and GenomeIndia genomics initiative, alongside a Biomarker Centre of Excellence focused on scalable blood-based diagnostic methods.

Differentiator

Problem solved

Functional benefit

Products and services

  • CBR-SANSCOG Study A first-of-its-kind longitudinal aging cohort study in India focusing on the rural aging population in Srinivaspura, designed to identify risk and protective factors for dementia and cognitive decline through multi-year clinical, cognitive, biochemical, and neuroimaging assessments.
  • CBR-TLSA Study (Tata Longitudinal Study on Aging) A longitudinal aging cohort study on urban residents of Bangalore, India, funded by Tata Trusts, investigating cognitive trajectories, biomarkers, and risk factors for dementia in an urban Indian population.
  • YLOPD Study A longitudinal study on Young and Late-onset Parkinson's Disease investigating clinical, genetic, and biochemical characteristics of Parkinson's disease in the Indian population.
  • GenomeIndia Initiative A comprehensive catalog of genetic variations for India's population designed to capture the unique genetic diversity across the country, including a milestone of sequencing 10,000+ genomes.
  • Biomarker Centre of Excellence A dedicated center for systematic evaluation of blood biomarkers and discovery of new biomarkers relevant to the Indian population, including development of scalable finger-prick testing methods for early detection of dementia and neurodegenerative diseases.

Quantifiable outcome

  • Sequenced 10000 genomes milestone achieved
  • +2 more outcomes

Companies that use Centre for Brain Research (CBR) IISc

Customer profile

Named customers1 record

Segments1 record

Ideal customer profiles3 records

Centre for Brain Research (CBR) IISc technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature7 records

Centre for Brain Research (CBR) IISc partnerships and signals

Strategic signal

Partnerships

Four partnerships are on record, tiered core and minor.

  • Gates VenturescoreStrategic or Co-development Partner · 9 April 2025MoU signed April 2025 to establish long-term association on scientific research and capacity-building in healthy brain aging. Combines CBR's clinical and scientific expertise with Gates Ventures' commitment to overcoming R&D challenges in Alzheimer's and related dementias. Leverages fluid biomarkers to predict onset and monitor progression of dementia. Establishes Biomarker Centre of Excellence at CBR for evaluating blood biomarkers and developing scalable finger-prick testing methods. Cooperation enabled via Alzheimer's Disease Data Initiative (ADDI) and Global Research and Imaging Platform (GRIP).
  • UK Dementia Research Institute (UK DRI)coreStrategic or Co-development Partner · 14 March 2025Landmark international partnership launched March 2025 to create a dynamic research ecosystem for brain health. Combines expertise in blood-based biomarkers, AI-driven data analysis, and digital cognitive monitoring tools. Leverages diverse population studies across India and UK, working with Health Data Research UK. Establishes cross-institutional collaboration mechanisms including research internships, joint educational initiatives, and resource sharing. Focus on fluid biomarkers characterization and AI-powered data infrastructure development.
  • Health Data Research UK (HDR UK)minorStrategic or Co-development Partner · 14 March 2025Partnership leveraging data and extensive epidemiological datasets to maximize research impact in brain aging research, working alongside UK DRI.
  • WiprominorStrategic or Co-development Partner · 28 May 2024AI-driven health behaviour innovations collaboration. Wipro teams up with CBR for AI-driven health behaviour innovations.

Scale indicators8 records

Recent moves6 records

Expansion highlights5 records

Centre for Brain Research (CBR) IISc competitors and assessment

Company assessment

Direct peers

  • Allen Institute for Brain Science: Non-profit neuroscience research organization generating large-scale open datasets, atlases, and tools. Comparable to CBR in combining large-scale data generation (CBR's 10,000+ genomes and cohorts) with a translational neuroscience mission.
  • UK Dementia Research Institute (UK DRI): UK's national dementia research institute, directly comparable as a brain-aging and neurodegeneration research organization. CBR and UK DRI signed an MoU in March 2025, integrating biomarker, AI, and digital cognitive monitoring programs across India and UK cohorts.
  • Banner Alzheimer's Institute: Non-profit research organization focused on Alzheimer's disease prevention, early detection, and biomarker research. Comparable to CBR in dementia-specific translational research mission and population-based study orientation.
  • Salk Institute for Biological Studies: Independent non-profit biological research institute with strengths in neuroscience and age-related neurodegeneration. Comparable to CBR in non-profit research mission and bench-to-translational pipeline structure.
  • Buck Institute for Research on Aging: Independent non-profit research institute focused on aging and age-related disease, including neurodegeneration. Comparable to CBR's research-only structure, disease-mechanism focus, and translational aging science orientation.
  • Max Planck Institute for Biology of Ageing: Germany-based non-profit research institute studying the biology of aging and age-related disease, including neurodegeneration. Comparable to CBR as a dedicated aging-and-dementia basic/translational research entity.
  • Mayo Clinic Alzheimer's Disease Research Center: NIH-designated Alzheimer's Disease Research Center combining longitudinal cohorts, biomarker discovery, and clinical translation. Comparable to CBR in disease-focused, multimodal biomarker + cohort infrastructure.
  • Rush Alzheimer's Disease Research Center: Academic research center running long-running longitudinal cohort studies of aging and dementia (e.g., Religious Orders Study, Memory and Aging Project). Directly comparable to CBR-SANSCOG/TLSA in cohort-based dementia risk-factor research.

Broad incumbents

  • National Institute on Aging (NIA/NIH): U.S. federal agency that funds and conducts Alzheimer's and related dementias research at scale, including the Alzheimer's Disease Research Center network. Comparable as the dominant funder/coordinator of dementia cohort and biomarker research in the U.S.

Regional players

  • Karolinska Institutet - Aging Research Center: Sweden-based academic research center studying aging, dementia, and cognitive decline through longitudinal cohorts (e.g., SNAC-K). Comparable scientific agenda to CBR but based in Europe, with similar population-cohort methodology.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

Centre for Brain Research (CBR) IISc social profiles

Digital presence

Centre for Brain Research (CBR) IISc financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Centre for Brain Research (CBR) IISc leadership team

Management profile

Number of profiles

Profiles6 records

Centre for Brain Research (CBR) IISc funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Centre for Brain Research (CBR) IISc M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Centre for Brain Research (CBR) IISc

What does Centre for Brain Research (CBR) IISc do?

The Centre for Brain Research conducts longitudinal aging cohort studies to understand normal and pathological brain aging, identify risk factors for dementia, and develop early detection biomarkers for Alzheimer's and related neurodegenerative disorders. Its core programs include the rural SANSCOG cohort, urban TLSA cohort, YLOPD Parkinson's study, and GenomeIndia genomics initiative, alongside a Biomarker Centre of Excellence focused on scalable blood-based diagnostic methods.

Is Centre for Brain Research (CBR) IISc a public or private company?

Centre for Brain Research (CBR) IISc is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was Centre for Brain Research (CBR) IISc founded?

Centre for Brain Research (CBR) IISc was founded in 2022. It employs 101 to 250 people.

Where is Centre for Brain Research (CBR) IISc based?

Centre for Brain Research (CBR) IISc is headquartered in Bangalore, India, in the Asia region.

How does Centre for Brain Research (CBR) IISc make money?

Three revenue lines are on record. Philanthropic Funding is the primary driver. The others are research Grants and donations.

Who are Centre for Brain Research (CBR) IISc's main competitors?

Direct peers on record are Allen Institute for Brain Science, UK Dementia Research Institute (UK DRI), Banner Alzheimer's Institute, Salk Institute for Biological Studies, Buck Institute for Research on Aging, Max Planck Institute for Biology of Ageing, Mayo Clinic Alzheimer's Disease Research Center and Rush Alzheimer's Disease Research Center. National Institute on Aging (NIA/NIH) is listed as a broad incumbent. Karolinska Institutet - Aging Research Center is listed as a regional player.

Does Centre for Brain Research (CBR) IISc have an API?

No public API is recorded for Centre for Brain Research (CBR) IISc.

What industry is Centre for Brain Research (CBR) IISc in?

Centre for Brain Research (CBR) IISc's product category is Neuroscience Research. Its primary akta.pro industry code is HLAKAIAH, Cognitive & Behavioral Neurology (Dementia/Memory Disorders). Its NAICS code is 624120 and its SIC code is 2835.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
The Indian ExpressDigital biomarkers can change the way we track dementia: Prof KVS Hari, Director, Centre for Brain Research, IIScKVS Hari serves as the director of the Centre for Brain Research (CBR), an autonomous non-profit research organization located at IISc in Bengaluru. The centre was established through a donation from the Pratiksha Trust, founded by Kris Gopalakrishnan of Infosys, to conduct research on aging brains and associated disorders.The Indian ExpressIs high blood sugar tipping you closer to dementia? Why a new multi-national study may have answersThe Madras Diabetes Research Foundation, the Centre for Brain Research in Bengaluru, and the UK Dementia Research Institute are collaborating on a multi-national study to investigate the link between diabetes and dementia. The research aims to identify early indicators of brain aging and develop preventive strategies by analyzing how hyperglycemia and hypoglycemia accelerate cognitive decline through vascular damage and protein accumulation.BusinessLineThree institutes collaborate to research diabetes connection with brain healthThe Madras Diabetes Research Foundation, the Centre for Brain Research at the Indian Institute of Science, and the UK Dementia Research Institute have signed memorandums of understanding to collaborate on researching the link between diabetes and brain health. The partnership aims to facilitate large-scale studies and data exchange to improve early detection and prevention strategies for cognitive decline and neurological diseases like dementia.